<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33590">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02065219</url>
  </required_header>
  <id_info>
    <org_study_id>H-3-2011-130-open</org_study_id>
    <secondary_id>2612-1006</secondary_id>
    <nct_id>NCT02065219</nct_id>
  </id_info>
  <brief_title>Trigger-point Blockade in Persistent Pain After Open Groin Hernia Repair</brief_title>
  <acronym>Trigger-open</acronym>
  <official_title>Trigger-point Blockade in Persistent Pain After Open Groin Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Groin hernia repair is a common procedure performed in approximately 2,000 patients per one
      million inhabitants. Severe chronic pain following groin hernia repair is seen in 2-5% of
      the patients indicating that a large number of patients each year suffer from debilitating
      reduction in health-related quality of life.

      This study examines the effect of ultra-sound guided blocks with local anesthesia in the
      groin in regard to pain relief and sleep quality.

      The hypothesis of the study is that a block will confer significant pain relief to patients
      with severe chronic pain following open groin hernia repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This placebo-controlled, randomized, double-blind, cross-over study in subjects with severe
      pain after open groin hernia, examines the effect of an ultra-sound guided local anesthetic
      block of a trigger-point, situated near the spermatic cord at the superficial inguinal ring.
      In order to compare effects and distribution of the blocks in patients vs. healthy subjects,
      the block is tested and examined in volunteers using a similar methodology.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Normalized summed pain intensity difference (SPID)</measure>
    <time_frame>20 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>The number of patients with normalized summed pain intensity differences (SPID) of more or equal to 50% after bupivacaine AND SPID less or equal to 25% after placebo.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Thermal thresholds</measure>
    <time_frame>20 min</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Quantitative changes in thermal thresholds (warmth detection threshold, cool detection thresholds, heat pain threshold) after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suprathreshold heat stimulation</measure>
    <time_frame>20 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quantitative changes in pain ratings to suprathreshold heat stimulation after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure pain thresholds</measure>
    <time_frame>20 min</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Quantitative changes in pain rating to pressure algometry stimulation after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory mapping</measure>
    <time_frame>20 min</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quantitative changes in area of cool hypoesthesia assessed by a thermal roller after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain questionnaire</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quantitative changes in summed pain intensity differences (SPIDs) during rest, movement and during auto-palpation, assessed morning and evening after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quantitative changes in sleep quality assessed each morning, after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection, 25 mg, once, 5 min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>injection, 10 ml 0.9% sodium chloride, once, 5 min</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>10 ml of bupivacaine 2.5 mg/ml deposited  by ultra-sound guidance around the spermatic cord</description>
    <arm_group_label>Bupivacaine</arm_group_label>
    <other_name>Bupivacain &quot;SAD&quot;</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with persistent pain (&lt; 6 mo) after open groin hernia repair

          -  Patients with maximal pain area 3 cm or less from the superficial inguinal ring

          -  Patients living in the Capital Region of Denmark (Region Hovedstaden) or the Region
             of Zealand (Region Sj√¶lland)

        Exclusion Criteria:

          -  Known allergy to bupivacaine or other local anesthetics of amide-type

          -  Declared incapable of making his/hers own affairs

          -  Does not comprehend Danish in the written or spoken language

          -  Cognitive impairment to a degree influencing the testing reliability

          -  Known recurrence of the  inguinal hernia

          -  Other surgical procedures performed in the groin or on the external genitals

          -  Neuropathy affecting the groin region caused by other conditions, e.g. post-stroke,
             multiple sclerosis, herniated intervertebral disc

          -  Abuse of alcohol or drugs

          -  Unable to cooperate with the sensory examinations
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mads U Werner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Multidisciplinary Pain Center, Neuroscience Center, Rigshospitalet, Copenhagen University Hospital, DENMARK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henrik Kehlet, MD</last_name>
    <role>Study Director</role>
    <affiliation>Section of Surgical Pathophysiology, Juliane Marie Center, Copenhagen University Hospital, DENMARK</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mads U. Werner, MD</last_name>
    <phone>+4528257703</phone>
    <email>mads.u.werner@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Multidisciplinary Pain Center, Neuroscience Center, Copenhagen University Hospital, DENMARK</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mads Werner</last_name>
      <phone>28257703</phone>
      <email>mads.u.werner@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Nelun Wijayasinghe, MD</last_name>
      <phone>+4535457618</phone>
      <email>nelun.wijayasinghe@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Nelun Wijayasinghe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas K Ringsted, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joakim M Bischoff, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mads U. Werner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 14, 2014</lastchanged_date>
  <firstreceived_date>February 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>mads u werner</investigator_full_name>
    <investigator_title>MD, MDSc</investigator_title>
  </responsible_party>
  <keyword>Chronic Pain</keyword>
  <keyword>Inguinal Hernia</keyword>
  <keyword>Outcome</keyword>
  <keyword>Surgical Procedure, Operative</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
